Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

OrganiGram Holdings Inc T.OGI

Alternate Symbol(s):  OGI

Organigram Holdings Inc. is focused on producing cannabis for patients and adult-recreational consumers, as well as developing international business partnerships to extend the Company's global footprint. The Company, through its subsidiary, Organigram Inc., is a licensed producer of cannabis, cannabis- derived products and cannabis infused edibles in Canada. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O’ Buds, SHRED, SHRED’ems, Monjour, Laurentian, Tremblant Cannabis and Trailblazer. It specializes in vape and infused pre-roll categories backed by a portfolio of owned brands, including the BOXHOT brand. Its products include pre-milled flower, pre-rolls, weed gummies, shred x vapes, and extracts. It operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba. Its subsidiaries also include 10870277 Canada Inc.


TSX:OGI - Post by User

Bullboard Posts
Post by jfogarty12on May 29, 2020 6:01pm
355 Views
Post# 31090227

OK FOR $$$ CASH

OK FOR $$$ CASHOrganigram restructures debt deal with BMO, lenders

Organigram Holdings said Friday it struck a deal with the Bank of Montreal to modify the terms of some of its debt. Organigram has a $115-million term loan and $25-million credit facility with BMO as well as three other lenders, the company said in a statement. The new agreement extends the final draw deadline for the term loan to the end of July, adjusts certain financial ratios the company needs to adhere to, and removes the option to increase the loan by an additional $35 million. Raymond James analyst Rahul Sarugaser said in a report that Organigram will remain "unhindered" by the new lender adjustments given the company's "very positive current trajectory."
Bullboard Posts